IntraLase Management to Present at Banc of America Securities - New Products, New Paradigms Specialty Pharmaceuticals Conference
IntraLase Corp. (Nasdaq:ILSE) today announced that Robert J. Palmisano, president and chief executive officer, and Shelley B. Thunen, executive vice president and chief financial officer, will make a presentation to investors and financial analysts during the Banc of America Securities "New Products, New Paradigms" Specialty Pharmaceuticals Conference in Southampton, N.Y. The presentation is scheduled for Friday, July 29, 2005, at 11:15 a.m. Eastern.
A live webcast of the audio portion of the presentation will be available through the IntraLase website at www.intralase.com or by clicking on https://www.veracast.com/webcasts/bas/sp05/id95206177.cfm. A replay of the webcast will be available at both sites until August 12, 2005.
About IntraLase Corp:
IntraLase designs, develops and manufactures an ultra-fast laser, related software and disposable devices used to create a corneal flap, the first step in LASIK surgery for the correction of vision. The company's products improve the safety, precision and visual results of LASIK procedures by providing a computer-controlled laser solution in place of the hand-held mechanical, metal-bladed microkeratome traditionally used to create corneal flaps. IntraLase lasers are also used in surgical approaches to the treatment of diseased corneas. The company's lasers and disposable per procedure patient interfaces are presently marketed throughout the United States and 21 other countries. IntraLase is headquartered and manufactures its products in Irvine, Calif. For additional information, visit the company's web site: www.intralase.com.
via Link [www.genengnews.com/news/bnitem.aspx?name=1016642XSL_NEWSML_TO_NEWSML_WEB.xml]